Dr CYJ Hair Filler: What Is in the Syringe and What Studies Show
You notice that your part is widening and more scalp shows in photos taken under bright light. Someone suggests Dr CYJ Hair Filler, and you want to know what a “hair filler” actually is rather than simply trust a promise of thicker hair. Dr CYJ Hair Filler is an injectable scalp product containing hyaluronic acid and peptides. It has been studied as a possible adjunct for some types of hair loss, but large, convincing comparative trials are insufficient to promise restored density. It is not a transplant, cannot create new follicles on demand and does not replace finding out why hair is falling out.
The decision should not start with the number of syringes. First determine whether this is gradual thinning from androgenetic alopecia, temporary shedding after illness or stress, scalp inflammation or a condition capable of permanently damaging follicles. Those situations call for fundamentally different plans.
What is in the syringe, and is it an ordinary filler?
The DR. CYJ HAIR FILLER described in medical-device registrations is made by Caregen in South Korea: a sterile gel in a prefilled 1 ml syringe. Malaysia's medical-device register describes non-animal-derived 0.7% hyaluronic acid and a peptide complex. The manufacturer lists seven peptides: octapeptide-2, decapeptide-10, octapeptide-11, decapeptide-18, decapeptide-28, oligopeptide-54 and oligopeptide-71. These details identify a specific device; they cannot be applied to any similarly named “hair cocktail.”
Hyaluronic acid forms part of the injectable carrier; the peptides are claimed to affect processes involving hair follicles. Laboratory discussions of hair-growth signalling offer a plausible hypothesis, not proof that the product improves a particular person's hair. The term “filler” can mislead: it does not add volume to the face or mechanically fill a thinning area with hair. Its intended site, formulation and injection technique are different.
Do not confuse the original Hair Filler with Hair Filler Cocktail products, cosmetic tonics or generic mesotherapy. Even use of the same brand name does not establish the same route of administration, indications or regulatory status. Ask to see the exact product name, batch number, expiry date and instructions for the version that would be used.
What do registrations and studies establish — and what remains a claim?
Malaysia's public device register lists a DR. CYJ HAIR FILLER registration valid from 26 May 2023 to 25 May 2028 under one local representative; a separate 2026 listing for the same brand name runs from 25 June 2026 to 24 June 2031 under another representative. Neither listing alone proves that two different formulations are involved. These are Malaysian registrations, not authorisation in Armenia, proof of stock at a clinic, or US FDA approval. Distributor statements about European CE marking require checking the current certificate, scope and applicable legal rules. A device registration and proof of clinical benefit are separate questions.
One published 2024 pilot study followed 12 men with androgenetic alopecia who underwent four treatments over eight weeks; hair measures were assessed six months later. Some density measures rose, but the researchers used needle-free pneumatic jet delivery. There was no control group, the sample was small, and follow-up was limited. The effect of the formulation cannot be separated from effects of the delivery technique. Its percentages cannot be transferred to standard needle injections, women, other diagnoses or everyone considering treatment.
Manufacturers and sellers promote reduced shedding and stimulated growth and sometimes show dramatic photos. These are claims about how the product is positioned, not guarantees. Stronger conclusions would require adequately sized, independent randomised comparisons involving matching diagnoses, consistent application methods, long-term follow-up and systematic adverse-event reporting. Based on the brand-specific studies reviewed through October 2026, it is more accurate to describe an uncertain potential adjunctive benefit than a proven replacement for established treatments.
| What you see | What it tells you | What it does not prove |
|---|---|---|
| Contents and intended purpose in a register | Details of a device registered in a stated country | Worldwide authorisation or suitability for every alopecia |
| Manufacturer's directions and schedule | Suggested use of that product version | An optimal schedule or predictable success |
| Small study of 12 men | Preliminary findings worth testing further | Effectiveness of ordinary needle injections or lasting results |
| Before-and-after photos | How a selected person looked under selected conditions | That the effect is typical or caused by this product alone |
For which type of hair loss might injections be discussed?
When hair is gradually becoming finer while the scalp looks healthy, a doctor may consider androgenetic alopecia: inherited follicle sensitivity to hormonal signals. Even then, better-established options are usually considered first. Dr CYJ might be discussed only as an additional option if a clinician has examined you and can explain the goal, evidence limitations and alternatives.
If shedding suddenly increased after infection, fever, surgery, restrictive dieting or another event, telogen effluvium may be responsible: more hairs enter the resting phase. Sorting out the trigger, nutrition, medication, other health conditions and expected course matters more initially. Injections should not be the automatic answer to abrupt shedding. Round bald patches, skin changes, itching or tenderness call for a different assessment.
A critical distinction is scarring alopecia. Certain inflammatory diseases can destroy follicles permanently. Smooth areas with no visible follicle openings, redness, scaling around individual hairs, pustules, pain or rapidly spreading patches warrant prompt dermatology assessment rather than booking cosmetic injections.
| Situation | Reasonable next step | Where Dr CYJ fits |
|---|---|---|
| Gradual thinning, calm scalp | Clarify alopecia type, severity and core treatment plan | Possible adjunct to discuss, with limited evidence |
| Sudden widespread shedding | Review recent events and medical causes | Not a first choice before identifying the cause |
| Patches, pain or pronounced inflammation | Prioritise in-person dermatology diagnosis | Postpone until diagnosis and disease control |
| Long-standing smooth bald area | Assess whether follicles remain and discuss other options | Do not promise regrowth of absent follicles |
What does treatment involve and how uncomfortable is it?
In an ordinary needle-based session, the practitioner cleans the scalp and makes multiple superficial injections into planned areas. It is not one injection in one spot: there may be many entry points. You may feel brief pricks, stinging or pressure, and scalp sensitivity varies. Local anaesthesia may sometimes be discussed, but its ingredients, allergy risks and duration need their own assessment. Needle-free jet administration in the pilot study is a different technique: its pain and efficacy observations cannot be transferred to ordinary needles.
Manufacturer materials describe four appointments at two-week intervals, with possible maintenance visits. This is a manufacturer protocol, not a universal medical standard. Before beginning, agree on the number of proposed treatments, total cost, objective outcome measures and what happens if no benefit is seen. The existing evidence does not support a promise of “full thickness in four sessions.”
Tell the clinician about chronic illnesses, infection, unusual bleeding, past reactions, anticoagulants and other medications, and previous scalp procedures. Do not stop prescription drugs on your own for injections. During pregnancy or breastfeeding, with active scalp infection or inflammation, unexplained bald patches or a possible ingredient allergy, postponing an elective course pending assessment is prudent. Verify exact restrictions against authentic instructions for the specific batch rather than an advertisement.
What will be visible tonight and tomorrow?
On treatment day, small red puncture marks, tenderness, transient swelling, spots of blood or bruising can occur. Hair may look flattened or separated into partings after the scalp is cleaned. You might feel well enough for everyday tasks, but being medically fit for work is not the same as the scalp looking untouched for a photo shoot, presentation or exposed-hair style. Allow a buffer for individual healing; there is no reliable universal deadline for marks to disappear.
Some people have very little to show the following day; others have redness or soreness for longer. Avoid scheduling a first session immediately before a wedding, trip or significant event. Agree with the practitioner when you can wash and style hair, dye it, exercise, use a pool or sauna, taking account of the technique and your skin. Keep dirty hands off punctures; do not try to massage the product into place or apply irritating products to injured skin.
Severe or increasing pain, spreading redness, fever, pus, substantial swelling or unexpected skin discolouration calls for urgent medical assessment. Difficulty breathing, widespread hives or tongue/throat swelling calls for emergency assistance. Injections carry infection, allergic, bleeding and tissue-injury risks; a small series with no major reported events cannot rule out rare complications.
When can you assess the hair without misleading yourself?
Hair grows slowly; what you see that evening cannot establish that more follicles exist or hair growth has improved. Set comparison points months apart rather than taking daily pictures in different lighting. Use the same part, camera distance, hair length, moisture and light; if available, phototrichogram measurement can track hair count and shaft calibre in the same marked area.
If you are also taking medicines, improving nutrition or recovering from telogen shedding, a photo cannot isolate Dr CYJ's contribution. Fewer hairs on your brush is not by itself reliable: shedding naturally fluctuates. Agree on the starting diagnosis, comparable measurements and a stopping rule before you begin. Lack of improvement is a reason to reconsider the plan, not an automatic reason to buy more syringes.
What alternatives should you compare without pressure?
For inherited thinning, minoxidil and, when indicated, other prescription medicines have more established evidence, though none ensures full regrowth and they have limitations and require time. Low-level light therapy may offer a non-injection option; its evidence also depends on diagnosis and exact device. PRP injects platelet-rich plasma prepared from your own blood and has heterogeneous protocols and results. Transplantation redistributes existing follicles and is a separate surgical decision.
Compare the confirmed diagnosis, realistic degree of change, research quality, invasiveness, repeat appointments, complete cost and what happens if you decline. Observation, gentle care, a hairstyle change or cosmetic concealers can be entirely reasonable if the scalp is healthy. You are not obliged to have injections.
Questions to ask before agreeing
- What diagnosis explains my pattern, and how was it established? Would dermoscopy of the scalp (trichoscopy) or targeted tests help?
- Is this genuine DR. CYJ HAIR FILLER rather than another cocktail? May I inspect the instructions, expiry, packaging, batch and documents showing lawful supply in this country?
- Which publications studied this exact injection technique? Are there controlled trials rather than selected photos or presentations?
- What risks apply with my medication and scalp condition? Who will perform it and manage a complication?
- Which measurable changes and dates will determine continuing or stopping? What is the total cost including follow-up?
If no one can distinguish registration from proof of effectiveness, show the packaging or offer diagnosis before selling a large course, taking more time is reasonable. A consultation is not consent to inject. Clear limits matter more than a spectacular image.
Further questions
Can a partly used syringe be saved for a later visit?
The registered device described above is specified for single use. Leftovers must not be stored by patients, shared between people or reused at a later visit instead of a new sterile unit.
Can injections be placed only along the visible part?
The treatment area is chosen after examining the whole pattern: a visible part does not necessarily show all thinning zones. Injection placement should not be determined solely from a picture or a request to “treat where it shows.”
Should I stop minoxidil before the course?
Do not discontinue prescribed treatment yourself. Evidence on combinations is limited; ask your dermatologist when to apply topical medication around injections to avoid irritating skin while maintaining your main therapy.
Sources and further reading
- DR. CYJ HAIR FILLER registration — Medical Device Authority Malaysia (one registry entry; separate 2026 listing noted above).
- Additional Malaysian DR. CYJ HAIR FILLER registry entry (2026) — Medical Device Authority Malaysia.
- Naranjo and Vinshtok, 2024 pilot study — Journal of Cosmetics, Dermatological Sciences and Applications.
- DR. CYJ Hair Filler product information — distributor marketing, not independent proof of efficacy.
- Diagnosing hair loss — American Academy of Dermatology.
- Male-pattern hair loss information — British Association of Dermatologists.